• Skip to content

Ceramisphere Health

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-163800918-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-163800918-1'); </script>

  • Home
  • About
    • Ceramisphere Health
    • History
    • People
    • Facilities
    • Technology
      • Ceramisphere Encapsulation Technology
      • Key Features and Benefits
  • Pipeline
    • Pipeline Overview
    • Lidocaine Patch
    • Controlled Drug Patch
    • EGF Patch
  • Investors
    • Technology Summary
    • Opportunity
    • Market & Opportunity for Lidocaine Patches
    • Market & Opportunity for Fentanyl Patches
    • Market & Opportunity for EGF Patches and Bioactive Wound Dressings
  • News
  • Downloads
  • Contact

About

ABOUT US

CERAMISPHERE HEALTH

  • Ceramisphere Health Pty Limited is a recent spin-off from Ceramisphere Pty Ltd, a privately-owned micro-encapsulation company established in 2007. We are based in Sydney, Australia, where we undertake product development, scale-up, and production of silica based drug delivery systems.
  • At Ceramisphere Health, we focus on product development to improve patient comfort and compliance with high patient acceptability. We are developing innovative and user-friendly drug delivery solutions through structured commercial relationships with world leading healthcare and animal health companies. Our current focus is the development of pioneering skin delivery based solutions for small and large therapeutic molecules.
CERAMISPHERE HEALTH
ADVANCED DRUG DELIVERY
We are an Australian based drug delivery company focused on the development of our “zero-waste” transdermal patches for the delivery of analgesics with an emphasis on controlled drugs for pain-relief and for development of smart bioactive wound care products with minimal pain and scarring. We are seeking partners to help us progress our “zero-waste” nanocomposite patch technology through early clinical trials with a view to license the technology for specific therapeutic applications to patch or wound dressing manufacturers or pharmaceutical companies.
Read More
  • Home
  • About
  • Contact
  • Downloads
COPYRIGHT © CERAMISPHERE 2023
Privacy Policy Terms & Conditions